Cargando…

Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial

Nafamostat mesilate (NM), a synthetic serine protease inhibitor, has been used increasingly as an anticoagulant during continuous renal replacement therapy (CRRT). However, there, are limited data from randomized studies on NM use in patients with a bleeding tendency. This prospective study evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Ji-Young, Kang, Yun-Jeong, Jang, Hye Min, Jung, Hee-Yeon, Cho, Jang-Hee, Park, Sun-Hee, Kim, Yong-Lim, Kim, Chan-Duck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291631/ https://www.ncbi.nlm.nih.gov/pubmed/26717390 http://dx.doi.org/10.1097/MD.0000000000002392

Ejemplares similares

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
por: Han, Sang Jin, et al.
Publicado: (2011)

The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation
por: Lee, Jae Ha, et al.
Publicado: (2022)

Utility and safety of nafamostat mesilate for anticoagulation in dogs
por: Isayama, Noriko, et al.
Publicado: (2022)

Depressive Symptoms, Patient Satisfaction, and Quality of Life Over Time in Automated and Continuous Ambulatory Peritoneal Dialysis Patients: A Prospective Multicenter Propensity-Matched Study
por: Jung, Hee-Yeon, et al.
Publicado: (2016)

Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment
por: Han, Sung Joon, et al.
Publicado: (2018)

Cardiac arrest caused by nafamostat mesilate
por: Kim, Hyo Shik, et al.
Publicado: (2016)

Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study
por: Cho, Jang-Hee, et al.
Publicado: (2015)

Ability of Nafamostat Mesilate to Prolong Filter Patency during Continuous Renal Replacement Therapy in Patients at High Risk of Bleeding: A Randomized Controlled Study
por: Lee, Yong Kyu, et al.
Publicado: (2014)

Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism
por: Kim, Do Hee, et al.
Publicado: (2016)

The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
por: Kim, Joo Seong, et al.
Publicado: (2022)

Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy
por: Jung, Su-Young, et al.
Publicado: (2016)

Nafamostat mesilate promotes endothelium-dependent vasorelaxation via the Akt-eNOS dependent pathway
por: Choi, Sujeong, et al.
Publicado: (2016)

Renal hemosiderosis secondary to intravascular hemolysis after mitral valve repair: A case report
por: Lee, In Hee, et al.
Publicado: (2020)

Nafamostat Mesilate: Can It Be Used as a Conduit Preserving Agent in Coronary Artery Bypass Surgery?
por: Yoon, Yoo Sang, et al.
Publicado: (2013)

Cardiac arrest caused by nafamostat mesilate: Kounis syndrome in the dialysis room?
por: Koniari, Ioanna, et al.
Publicado: (2017)

Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance
por: Kitaura, Atsuhiro, et al.
Publicado: (2023)

Early critical cortical infarction by anti-angiotensin II type 1 receptor antibody: A case report and literature review
por: Lim, Jeong-Hoon, et al.
Publicado: (2021)

Lactate clearance is associated with mortality in septic patients with acute kidney injury requiring continuous renal replacement therapy: A cohort study
por: Passos, Rogério da Hora, et al.
Publicado: (2016)

Concurrent pituitary apoplexy and posterior reversible encephalopathy syndrome in a patient with end-stage renal disease on hemodialysis: A case report
por: Lee, In Hee, et al.
Publicado: (2020)

Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
por: Uwagawa, Tadashi, et al.
Publicado: (2022)

Nafamostat Mesilate Inhibits TNF-α-Induced Vascular Endothelial Cell Dysfunction by Inhibiting Reactive Oxygen Species Production
por: Kang, Min-Woong, et al.
Publicado: (2015)

Intestinal tuberculosis in a patient with end-stage renal disease on hemodialysis: A case report
por: Lee, In Hee, et al.
Publicado: (2020)

Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis
por: Lin, Yao, et al.
Publicado: (2022)

Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: A 2-year prospective cohort study
por: Park, Hayne Cho, et al.
Publicado: (2020)

Duration of anuria predicts recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, Hee-Yeon, et al.
Publicado: (2016)

Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report
por: Lee, Juhan, et al.
Publicado: (2017)

Lower serum uric acid level predicts mortality in dialysis patients
por: Bae, Eunjin, et al.
Publicado: (2016)

Spontaneous rupture of a renal artery pseudoaneurysm in a hemodialysis patient: A case report
por: Lee, Seunghye, et al.
Publicado: (2021)

Severe hypokalemic paralysis and rhabdomyolysis occurring after binge eating in a young bodybuilder: Case report
por: Lee, Tae Won, et al.
Publicado: (2017)

Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells
por: Sugano, Hiroshi, et al.
Publicado: (2018)

Acute thrombosis of a transplanted renal artery after gastric ulcer bleeding in a patient with a long-term well-functioning renal allograft: A case report and literature review
por: Wu, Chung-Kuan, et al.
Publicado: (2016)

Superior outcomes of kidney transplantation compared with dialysis: An optimal matched analysis of a national population-based cohort study between 2005 and 2008 in Korea
por: Yoo, Kyung Don, et al.
Publicado: (2016)

Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
por: Villa, Luigi, et al.
Publicado: (2021)

Postoperative Fluid Overload is a Useful Predictor of the Short-Term Outcome of Renal Replacement Therapy for Acute Kidney Injury After Cardiac Surgery
por: Xu, Jiarui, et al.
Publicado: (2015)

The modulation of TRPM7 currents by nafamostat mesilate depends directly upon extracellular concentrations of divalent cations
por: Chen, Xuanmao, et al.
Publicado: (2010)

Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient
por: Shim, Kwang Eon, et al.
Publicado: (2020)

Real-world treatment patterns of renal anemia in hemodialysis patients: A multicenter cohort study performed using DialysisNet (RRAHD study)
por: Kim, Hyo Jin, et al.
Publicado: (2020)

Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis
por: Chen, Siqi, et al.
Publicado: (2021)

Effect of nephrology referrals and multidisciplinary care programs on renal replacement and medical costs on patients with advanced chronic kidney disease: A retrospective cohort study
por: Chen, Jui-Hsin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3kft4qgpgcvnil0vfrghn5roak